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Abstract 
 
Methylation of arginine residues in proteins is involved in modulation of a various 
protein-protein interactions. On the chromatin level H4R3 methylation is providing a 
signal integration step during myeloid  differentiation. In order to globally characterize 
the role of arginine methylation in signal integration and developmental processes we 
decided to map genomic loci marked by PRMT1 (Protein Arginine Methyl Transferase 1) 
via histone H4 arginine 3 methylation. For this, we used the myeloid leukemia cell line,  
HL60, which is known to differentiate along the  monocyte/macrophage or granulocyte 
lineage. We used chromatin immunoprecipitation and cloning to isolate genomic loci 
marked by this modification. After sequencing and in silico analysis we found that all of 
the genomic hits identified were intronic or within 5 kb of 5‘ ends of specific genes. The 
locations identified were enriched in conserved transcription factor binding sites of 
POU2F1, MEF-2 and FOXL1 factors. A significant  number of the genes in the proximity 
of the identified genomic loci are involved in signaling pathways and developmental 
processes including immune response of myeloid cells.  
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Introduction 
 
Immune responses are mediated through multiple signaling cascades. Proteins involved 
in these cascades have to transmit signals on the scale of seconds. Biological systems 
efficiently use posttranslational modifications of proteins in order to change very rapidly 
the conformation of signaling molecules (Pawson, 2000). These mechanisms are able to 
increase the number of effector molecules by as much as an order of magnitude. The 
array of known posttranslational modification is extremely wide; it includes from 
palmitoylation and ubiquitination to sumoylation, acetylation and methylation various 
posttranslational changes. One studying signaling networks has to take into consideration 
all of these modifications (Kabuyama, 2004).  
One of the lesser-appreciated protein modifications is methylation. Methylations were 
described early in the ‘70s, but the characterization in the ‘80s of the enzymes involved in 
the methylations gave a new impact to the study of processes mediated by methylation 
(Disa, 1986; Gallwitz, 1971). Recently a plethora of substrates were identified (Boisvert, 
2003) (Lee, 2002) (Wada, 2002) and the enzymes involved in demethylation were also 
described (Cuthbert, 2004; Shi, 2004; Wang, 2004). It is easy to see that this will further 
increase the pace of research on this field. 
 
We have recently shown that methylation on arginine residues of the H4R3 histone tail is 
modulating cellular transcriptional memory and provides a signal integration mechanism 
in the process of myeloid cell differentiation (Balint et al. submitted manuscript). HL60 
myeloid leukemia cells enter in a transient primed state during their differentiation, 
characterized by an increased level of H4R3 methylation. HL60 cells become more 
susceptible for retinoid signals in this primed state. By the removal from the media of 
differentiating agents, this primed state is lost after several cell divisions, thus showing 
that increased arginine methylation provides a signal integration step during cell 
differentiation. This state is characterized by an increased level of PAD4, the pepdydil-
deiminase responsible for demethylation of methyl-arginines via citrullination (Wang, 
2004) (Balint et al. submitted manuscript). 
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Arginine methylation, beside a general role in gene expression regulation, seems to 
modulate proteins involved in immunological processes (Boisvert, 2004) (Mowen, 2001). 
Chromatin immunoprecipitation studies previously established that PRMT1 is one of the 
first proteins involved on the chromatin level in the events that in a concerted manner 
lead towards transcription (Metivier, 2003). To further characterize how PRMT1 
modulates gene expression on the chromatin level we decided to isolate chromatin 
fragments that are methylated on arginine H4R3. For this we used a polyclonal antibody 
that recognizes specifically methylated H4R3 residues (Wang, 2004). The 
immunoprecipitated fragments were cloned and sequenced. Here we report that the 
immunoprecipitated fragments are more abundantly located in introns and a great 
majority of them contain conserved transcription factor binding sites. 
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Materials and Methods 
 
Chromatin Immunoprecipitation  
 
Chromatin immunoprecipitation was carried out as described by Kuo and Allis (Kuo, 
1999)  with modifications. Briefly: cells were fixed with 1% formaldehyde for 10 min at 
room temperature. Fixation was stopped by adding chilled glycine to a final 
concentration of 150 mM. Cells were scraped and washed twice with ice-cold PBS that 
contained proteinase inhibitors (1mM PMSF, 1µg/µl aprotinin and 1µg/µl pepstatin A). 
Nuclei were prepared by incubation for 10 min on ice in a buffer containing 5mM Pipes 
pH8, 85mM KCl, NP40 0.5% and proteinase inhibitors. After centrifugation with 3000g 
for 10 minutes at 4 °C, nuclei were resuspended in sonication buffer (1%SDS, 0.1M 
NaHCO3 and proteinase inhibitors), lysed on ice for 10 minutes and sonicated on ice to 
an average fragment size of 500 base pairs. Cell debris was pelleted twice by 
centrifugation with 10000g for 30min at 4°C in a bench-top centrifuge. Soluble 
chromatin was aliquoted and frozen in liquid nitrogen and stored on –70°C. For 
immunoprecipitation chromatin was diluted, 10-fold in an IP buffer (0.01%SDS, 1.1% 
Triton X-100, 1.2mM EDTA, 16.7 mM Tris pH8.1, 16.7 mM NaCl and proteinase 
inhibitors). 1 ml of diluted chromatin was precleared twice with 40µl, blocked protein A-
sepharose beads. Immunoprecipitation was carried out with specific antibodies purchased 
from Upstate Biotech and Abcam against modified histones as it follows: , #07–213 Anti 
dimethyl H4 Arg3 6µl/IP. Incubation with the antibodies was carried out overnight, on a 
rotating plate at 4°C. Complexes were collected with 40 µl blocked protein A Agarose 
(Upstate #16–157). Beads were pelleted, washed twice with each of the following 
buffers: buffer A (low salt 0.1% SDS 1% Triton X-100 2mM EDTA 20mM Tris pH8.1 
150 mM NaCl + PI), buffer B (high salt 0.1%SDS 1% Triton X-100 2mM EDTA 20mM 
Tris pH8.1 500 mM NaCl + PI), buffer C (0.25 M LiCl 1% NP40 1% sodium 
deoxycholate 1mM EDTA 10 mM Tris pH8.1+PI) and TE buffer (10mM Tris 10mM 
EDTA pH8+PI). Immunoprecipitated nucleosomes were eluted twice from beads with 
elution buffer (1% SDS, 0.1M NaHCO3) and eluates were combined. Crosslinks were 
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reversed by incubating for 6 hours at 65°C after adding 20µl 5M NaCl. Eluate was 
combined with 10 µl of 0.5M EDTA, 20µl 1M Tris pH 6.5 and 2µg Proteinase K and 
incubated for 1 hour at 45°C. DNA was recovered after phenol: chloroform extraction 
and ethanol precipitation using 20 µg of glycogen as a carrier. DNA was resuspended in 
50 µl of 50 ng/µl yeast tRNA (Invitrogen). 
 
Generating of Blunt Ends 
 
Protruding ends of the isolated DNA fragments were filled by treatment with Klenow 
enzyme as it follows.  
The DNA fragments from 10 independent chromatin immunoprecipitations were mixed, 
divided in 10 alliquotes, supplemented with 0.5µl of 2.5mM dNTP, 3U Klenow enzyme, 
3.5µl 10X Klenow buffer in a total of 35 µl reaction mix. Reaction was carried out at 
room temperature for 10 minutes and stoped by incubation for 10 minutes at 75 C°.  
 
Ligation and Plasmid Preparation 
 
Ligation was performed with 15 U (0.5µl) T4 DNA Ligase (Fermentas) with addition of 
PEG at 16C° overnight with a vector: insert ratio of 10:1according to the manufacturers 
recomendations. We used Zero Blunt® PCR cloning vector (Invitrogen). The ligation 
product was transformed in competent E. coli, shaked in SOC medium at 37 C° for 2 
hours and plated in Kanamycin containing plates according to the manufacturers 
recomandations. On the second day colonies were isolated, plated on 96 well plates in 
liquid medium and let to grow for 24 hours at 37 °C degrees. Medium was suplemented 
with 30% of glycerol and frozen at -70C°C. At the analysis of colonies an aliquot of the 
frozen medium was plated on kanamycin containing plates and individual colonies were 
grown up. Plasmids were isolated with Miniprep Wizard (Promega) according to the 
manufacturers recommendations. The size of the insert was verified with XbaI and 
BamH1 double digestion and PCR with M13 primers. Results were visualized by 
standard agarose gel electrophoresis in a 2% agarose containing gel.  
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Sequencing 
 
Sequencing of the insert was performed with standard M13+ sequencing primer 
according to the manufacturers recommendations of the ABI Big Dye Terminator 2.1 kit.  
 
In Silico Analysis 
 
In silico analysis of the sequences was performed as it follows: 
The sequences of plasmid origin were removed from the ends of the raw sequence and 
the resulting sequence was first analysed with NCBI Blast (Altschul, 1990). Sequences 
that past the quality control described in the results section were further analysed. In the 
second step the genomic location of the sequences was analysed with BLAT program 
(Kent, 2002) on the UCSC Human Genome Browser (Karolchik, 2003). Conserved 
regions, known genes, conserved transcription factor binding sites and the position of the 
analysed sequence towards these genomic elements was monitored. For annotation we 
used PANTHER Analysis. The PANTHER (Protein ANalysis THrough Evolutionary 
Relationships) (Mi, 2005) (Thomas, 2003) database allows complex annotation of 
proteins and genes. We selected the data described as “Molecular functions” and 
“Biological processes” of the Version 5.0 (release date Jan. 1, 2005). 
 
Results  
 
A key arginine methyltransferase of the mammalian cell is PRMT1. One of the 
methylation reactions mediated by this enzyme is the H4R3 methylation (Tang, 2000a). 
H4R3 methylation was shown to be linked with gene expression (Wang, 2001). 
Methylation of histones by PRMT1 makes them a better substrate for histone 
acetyltransferases and by this provides a mechanistic link between gene expression 
regulation and arginine methylation (Wang, 2001). We decided to map genomic loci of 
arginine methylation in a differentiation primed myeloid leukemia cell line using an 
unbiased technique. The  „Chip to clone” strategy was used previously to identify binding 
sites of transcription factors (Weinmann, 2001). Transcription factors have consensus 
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binding sites that can be identified by in silico analysis and several biochemical methods 
can be used to verify the binding. In the case of a transcriptional cofactor that binds to a 
whole array of sequence specific transcription factors and has a well defined enzymatic 
activity identification of the genomic loci it binds to can be problematic. The post 
translational modification produced by this cofactor can be used for such analysis. It was 
shown previously that posttranslational histone modifications localised to specific loci are 
produced on much wider genomic areas than the localization of the transcription 
cofactors responsible for them (Bernstein, 2005) (An, 2004). This phenomenon has not 
been explained yet, nonetheless we decided to use this observation in order to identify 
genomic loci marked by PRMT1 via H4R3 methylation. The localization of H4R3 
methylated loci was achieved by using chromatin immunoprecipitation with an antibody 
raised against methylated H4 arginine (Wang, 2004). This antibody should bind 
specifically to genomic loci marked by PRMT1 (Tang, 2000a; Wang, 2004).  
 
The „Chip to Clone” method is summarized in figure 1. Briefly, HL60 cells were treated 
with 1.25% DMSO for 16 hours to achieve a differentiation primed state characterized by 
increased H4R3 methylation. Cells were fixed with 1% formaldehyde, sonicated to an 
average fragment size of 500bp. Figure 2 shows the predominant DNA fragment size of 
the sheared chromatin. We used anti H4R3-metyl antibody and protein A-agarose beads 
to immunoprecipitate mono and dinucleosomes that presented this modification. Beads 
were washed extensivelly, and immunoprecipitated DNA purified. After isolation of 
DNA, protuding ends of the DNA elements were filled to create blunt ends. Generated 
fragments were cloned then in a low background vector, transformed and the individual 
colonies isolated. Plasmids from individual colonies were purified. Inserts were identified 
by restriction enzyme analysis and by standard PCR with vector specific M13 primers 
and agarose gel electrophoresis (Figure 3). Further analysis was carried out after 
sequencing the isolated plasmids.  
 
By sequencing 111 of these cloned sequences we found that 54 of the sequenced clones 
had DNA fragments substantially smaler than those which could originate from the 
immunprecipitated nucleosomes. These fragments, considered by us junk DNA, were 
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large enough to provide disruption of the lethal gene included in the plasmid but unlikely 
to originate from an immunoprecipitated nucleosme that contains a DNA fragment of at 
least 140 bp. 57 fragments were containing fragments longer than 150 bp, corresponding 
to mono-, di- or trinucleosomes. We decided to analyse in detail the genomic localization 
of these. First we performed a BLAST analysis with the identified sequences. 48 of them 
were of human origin, 7 of bacterial origin and two of them of salmon origin. The 
bacterial origin was probablly due to contamination with bacterial genomic DNA 
fragments and the salmon DNA from the salmon sperm DNA used as a blocking agent 
for the protein A agarose beads. 
 
We considered a match in the human genome a sequence with more than 95% identity 
along the blasted query sequence. At the further stages of the analyses of the sequences 
we used the following categories: 
1. sequence with unique localization: a sequence with a unique match in the human 
genome  
2. repetitive sequence: a sequence with a match in one of the known repetitive 
elements in the genome. In these cases the blasted querry gave hits in the number 
of thousands along various chromosomes. 
3. repeted sequences with unique localization: those sequences that were found 
several times in our library but had a unique genomic localization. 
 
From the 48 human sequences 38 of them provided us with a perfect match, that means 
the whole length of our query sequence could be alligned with more than 98% identity to 
a human sequence. In one case we found a duplicate location with identical score but 
both of these locations were in gene poor regions. The 38 human sequences contained 26 
unique sequences, 12 repeted unique sequnces and 10 repetitive sequences. From the 10 
repetitive sequences we found 6 unique repetitive sequences and 4 that were repetition of 
a single clone from the 6 previously mentioned. We decided to further analyse the 
genomic localisation of the 26 unique sequence hits with the UCSC genome browser. 
From the 26 analysed sequences we found 14 nearby known genes. We set up a cut off 
value of 10kb for the analyses of proximity of genes. 9 of the sequences were found in 
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introns, one at an intron exon overlap and 4 within 5 kb from 5‘ ends of genes. One hit 
was at 5‘ of a predicted promoter. 12 of them had no genes within 10kb. 6 of these had 
regions with conserved TF binding sites within 5 kb. Table 1 presents the names of the 14 
identifed genes, their locations on chromosomes, the location of immunprecipitated 
fragment, relative to the gene and the conserved transcription factor binding sites within 1 
kb relative to the immunoprecipitated fragment. 
 
PANTHER Analysis 
 
The PANTHER (Protein ANalysis THrough Evolutionary Relationships) (Mi, 2005) 
(Thomas, 2003) database allows complex annotation of proteins and genes. We selected 
the data described as “Molecular functions” and  “Biological processes” of the Version 
5.0 (release date Jan. 1, 2005). This annotation allowed us to align the identified genes 
along biological processes as shown in Table 2. Signaling, cell differentiation, immune 
response and development are frequently associated with the identified genes. 
 
Analysis of Conserved Transcription Factor Binding Sites 
 
Next we decided to analyse the conserved transcription factor binding sites (TFBS) in the 
5kb region of the 26 identified immunoprecipitated fragments regardless wheter there 
were located in the proximity of genes or not. We found 39 conserved TFBS, with 12 of 
them beeing present more than one time. In Table 3 we present those 6 TFBS that were 
present at least three times in this list, with their corresponding transcription factors, 
according to the Biobase library (Matys, 2003). Two of these were published to have 
conections with the family of protein arginine methyltransferases, namely MEF2 with 
PRMT4 (or CARM1) (Chen, 2002) and FOXO as being an inducer of BTG1 the activator 
of PRMT1 (Bakker, 2004). 
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Discussion 
 
The level of methylation on arginine residues depends on the level of methyl donor 
Adomet, the level of methyltransferases (PRMT-s) and the level of demethylases present 
in the cell at a specific point in time. Methylation of arginine residues is involved in 
multiple ways in immunological responses (Boisvert, 2005a). Methionine 
adenosyltransferase (EC 2.5.1.6) is a key enzyme of cellular metabolism and catalyzes 
the formation of S-adenosyl-methionine (Adomet) from l-methionine and ATP. Adomet 
is the main methyl donor of the cell, a precursor of polyamine synthesis of molecules 
such as spermine and spermidine (Moreira, 2004). An arginine group may be methylated 
to produce methyl-arginine, while the aminoacid L-arginine may be oxidized by NOS to 
produce citrulline and NO and may be hydrolyzed by arginase to produce ornithine and 
urea. Importantly, methyl-arginine groups may be de-iminated to form citrullinated 
proteins. The link between Th1 and Th2 switch regarding arginase or NOS was described 
previously (Moreira, 2004) (Bronte, 2003) (Hesse, 2001). Th1 cytokines (INFγ and 
TNFα) induce NOS and produce NO release while Th2 cytokines (IL4 and TGFβ) induce 
Arginase. NO in the culture medium is an extreamly potent inhibitor of T cell 
proliferation. On the other hand arginase induction by IL4 depletes arginine from the 
enviroment and by this also blockes T cell proliferation (Bronte, 2003). LPS treatment of 
macrophages or the presence of  both IL4 and INFγ activates NOS and arginase at the 
same time. This is producing  arginine depletion as a result of arginase activity and is 
switching NOS to produce O2− in addition to NO and by this the formation of 
peroxynitrite is achieved. Peroxynitrite will favor the nitrosylation of several signaling 
mollecules and interferes by phosphorylation on thyrosine residues. In activated T 
lymphocytes the enzymes responsible for synthesis of the main methyl donor molecule, 
Adomet, namely MAT II, MAT I/III were shown to be markedly upregulated (Halim, 
2001; LeGros, 1997; LeGros, 2001). This means that in activated T cells there is an 
increase in the Adomet level and a depletion of arginine, two modifications that favor 
methylation of arginine residues of the proteins. One may assume that the inhibition of 
tyrosine phosphorylation by nitrosylation and activation of arginine methylation will 
further broaden the translation of specific immunological signals into distinct genetic 
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programs. Identification of protein substrates that may be methylated on arginine residues 
was carried out in several studies. Protein arrays, differential cloning and proteomic 
approaches were used to identify these substrates (Boisvert, 2003; Lee, 2002; Wada, 
2002). 
 
The enzymes involved in arginine methylation, members of the PRMT (protein arginine 
methyltransferase) protein family use as substrates arginine-glycine rich protein stretches 
(Wada, 2002) (Lee, 2002) and S-adenosine-methionine in order to catalyze the 
methylation reaction. PRMT1 is the main enzyme in the mammalian cell responsible for 
methylation of arginine residues (Tang, 2000a).  
 
Involvement of arginine methylation in immunological processes is suggested by several 
reports. One of the first reports about the involvement of PRMT1 in regulation of 
immune responses was the publication of direct interaction between IFNAR1 (a 
component of INFα/β receptor complex) and PRMT1 (Abramovich, 1997).  
 
STAT proteins that bind to INF receptors seem to be also modulated by arginine 
methylation. In particular methylation on arginine residues was reported as being 
involved in regulation of STAT1 (Mowen, 2001). Hypomethylated STAT1 presents a 
stronger interaction between STAT1-PIAS1 that alters STAT1 –DNA binding and this 
means that methylation of arginine residue in STAT1 is needed for the proper function of 
this molecule. On the other hand a member of JAK protein complex, JBP1 (JAK binding 
protein 1) was found to be another arginine methyltransferase, namely PRMT5 (Pollack, 
1999). On the level of gene expression regulation, NFAT- one of the main transcription 
factor involved in cytokine gene expression- is activated by the presence of the arginine-
methylated cofactor, NIP45 (Mowen, 2004) (Hodge, 1996). 
 
If one takes a closer look at the main arginine methyltransferase of the cell, PRMT1 
could be considered an apparently promiscuous protein. Methylation of STAT1 and 
NFAT, cofactor of nuclear receptors, DNA damage checkpoint control (Boisvert, 2005b) 
regulation of splicing was all described as involving PRMT1. One of the known 
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methylation reactions mediated by this enzyme is the methylation on the tail of histone 
H4 arginine residue in position 3. This modification is specific to PRMT1, while another 
methyltransferase, PRMT4 or CARM1, is involved in the arginine methylation in 
position 17 of the H3 histone tail. During embryonic development the expression of the 
PRMT1-reporter fusion gene was greatest along the midline of the neural plate and in the 
forming head fold from embryonic day 7.5 (E7.5) to E8.5 and in the developing central 
nervous system from E8.5 to E13.5. 
 PRMT1 -/- animals die between the embryonic day E4.5 and E6.5 between implantation 
and gastrulation suggesting that the modification is crucial for organ development in the 
body (Pawlak, 2000). Interestingly PRMT1 -/- ES cells are viable and are dividing, 
suggesting that this enzyme is not indispensable for life per se (Pawlak, 2000).  
 
We decided to further characterize the links between gene expression regulation and 
arginine methylation by PRMT1. HL60, myeloid leukemia cell line if primed with 
DMSO shows an increased level of H4R3 methylation. This state is characterized by a 
transient, increased sensitivity towards retinoid signals and by this provides a signal 
integration step in cell differentiation processes. We used this cellular state to identify 
genomic loci marked by PRMT1. We used chromatin immunoprecipitation to identify 
genomic loci marked by PRMT1 with H4R3 methylation. The isolated fragments were 
cloned into a low background vector and isolated. After sequencing of 111 isolated 
colonies we identified 26 fragments that had a fragment size corresponding of mono, di- 
and tri-nucleosomes. 14 of these sequences were intronic or within the 5kb to 5‘ ends of 
known genes. Regulatory regions show a higher degree of conservation during evolution 
(Liu, 2004). This is why identification of conserved transcription binding sites in the 
proximity of H4R3 arginine methylated chromatin streches is a sign of the relevance of 
the specific loci. We found 39 conserved TFBS, with 12 of them being present more than 
one time. In table 3 we present those 6 TFBS that were present at least three times in this 
list, with their corresponding transcription factors, according to the Biobase library 
(Matys, 2003). Two of these were published to have conections with the family of protein 
arginine methyltransferases, namely MEF2 with PRMT4 (or CARM1) (Chen, 2002) and 
FOXO as being an inducer of BTG1 the activator of PRMT1 (Bakker, 2004). 
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To annotate the identified genes we used the PANTHER (Protein ANalysis THrough 
Evolutionary Relationships) (Mi, 2005) (Thomas, 2003) database. From the 14 genes 3 
remained unclassified. The 9 classified genes contained 1 structural protein (Collagen 
9A1), 1 amino acid transporter (SLC36A1), all the other genes are involved in signaling, 
cell differentiation, immune response and development. 
 
To illustrate the possible connection between the H4R3 modification and its role in 
regulation of immune responses by PRMTs we summarize the known data regarding one 
of the identified sequence, the one located in the promoter of IL1α. IL1α was shown to 
be expressed in both blood poly-morphonuclear (PMN) and mononuclear (MNL) cells 
(Lord, 1991). Moreover IL1α  in the presence of histamine or PGE2 controls the 
expression of IL1β (Vannier, 1993). 
One of the genomic localizations identified by this screen is at 3kb upstream from the 
transcription start site of the gene IL1α. This location is on chromosomal band 2q13. Two 
conserved transcription binding sites are found within 2kb towards the 5 prime end of the 
gene V$FOXP1_01 V$BRN2_01 responsible for binding of FOX P1a and POU3F2. 
More interestingly in the first intron, at 5 kb from our located sequence two conserved 
transcription factor binding sites V$YY1_Q6 and V$COUP_01 are located that bind 
YY1 and COUP TF respectivelly. 
 
PRMT 1 was shown to interact with YY1 and this interaction results in histone arginine 
methylation (Rezai-Zadeh, 2003). YY1 forms a complex with PRMT1 mediated by 
DRBP76 called also ILF3 (Interleukin enhancer factor 3) (Rezai-Zadeh, 2003). This 
complex favors H4R3 methylation and subsequent acetylation. The activated gene is 
transcribed and RNA formed. Arginine methylation controls elongation  also, via SPT5. 
SPT5 a regulator of elongation is also methylated on arginne residues by both PRMT1 
and PRMT5 on partially overlaping methylation sites (Kwak, 2003). 
 
At the RNA methyltransferase complex level, PRMT1 and PRMT5 (JKB1-janus kinase 
binding protein1) produce asymmetric and symmetric methyl arginines (Yanagida, 2004). 
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After splicing and formation of mRNA, ILF3 through its RNA binding domain binds the 
formed mRNA and interacts with exportin5 (Brownawell, 2002). This interaction 
between ILF3 and cytokine mRNA was reported to stabilize the formed mRNA molecule 
(Shim, 2002). This stabilisation is concomittant with the export from the nucleus via 
XPO5 (expontin 5) which is a Ran Gtp mediated process (Brownawell, 2002; Gwizdek, 
2004). This stabilization of cytokine mRNA during nuclear export was documented for 
IL2 mRNA molecule (Shim, 2002). 
Quite interesting members of ILF family (ILF1 and ILF2) were published as being 
methylated on arginine residues in a proteomic approach (Boisvert, 2003), while ILF3 on 
a protein array (Lee, 2002). ILF3 was shown to be an activator of the methyltransferase 
activity of PRMT1 (Tang, 2000b). If taking together these data one may formulate an 
attractive hypothesis that arginine methylation seems to control the expression of IL1 
citokines at various levels from chromatin level through splicing and nuclear export till 
mRNA stabilization. Although these levels are separated in time and space according to 
the classical gene expression regulation point of view, the presence of PRMT1 at various 
levels fits well in the unified theory of gene expression (Orphanides, 2002) and arginine 
methylation might be a comon regulator of these processes.  
 
Summary 
 
In order to further characterize the role of arginine methylation in signal integration and 
developmental processes we carried out mapping of the genomic loci marked by PRMT1 
via histone H4 arginine 3 methylation. For this we used HL60 cell line previouslly shown 
to enter in a transient, primed state characterized by increased H4R3 methylation. We 
used chromatin immunoprecipitation and cloning to isolate genomic loci marked by 
H4R3 methylation. After sequencing and in silico analysis we found that all of the 
genomic hits identified were intronic or at 5‘ end of specific genes. The locations 
identified were enriched in conserved transcription factor binding sites of POU2F1, 
MEF-2 and FOXL1 factors. A great number of the genes in the proximity of the 
identified genomic loci were involving signaling pathways and developmental processes. 
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Furhter analysis of the identified loci needs to be done in order to decipher the role of 
arginine methylation in regulation signaling pathways and gene expression. 
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Figure legends 
 
Figure 1.  
Overview of the Chip to clone method. (1) Protein - DNA interactions in a cell result in 
specific post-translational modifications on the histone tails. (2) Protein - DNA 
interactions are fixed with 1% formaldehyde. (3) Chromatin is sheared by sonication to 
mono-, di- and tri-nucleosomes. (4) Specific antibodies against modified histone tails will 
bind the H4R3 methylated nucleosomes. (5) Antibodies bind to Protein A beads. (6) 
Nucleosomes with methylated arginine residues are isolated by extensive washing and 
centrifugation of Protein A beads. (7) DNA is isolated (8) Isolated DNA fragments are 
cloned in a low background vector.  
 
Figure 2  
Average fragment size of the sonicated DNA. Lanes 1-3 show an increasing amount of 
purified sonicated DNA, while M refers to the marker. 
 
Figure 3 
Distribution of different fragments after BLAST and BLAT analysis as described in the 
Results section. (A) 54 fragments from 111 analysed were of expected size (larger than 
150bp). (B) 48 of these 54 fragments were of human origin. (C) 26 human unique 
sequences were considered for BLAT analysis. (D) 14 hits are within 5kb of known 
genes. 
 
Figure 4 
Cloned fragments are identified with vector specific PCR using M13 primers. The 
product was run on a 2 % standard agarose gel by electrophoresis. Different lanes show 
different isolated clones and M refers to the marker.  
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Figure5  
Genomic context of the identified H4R3 methylated site in the promoter of IL1α. 
Conserved transcription binding sites, and the cloned fragment are shown with arrays.  
 
Table 1 
Genes identified by cloning H4R3 methylated nucleosomes, their chromosomal locations, 
their position towards the genes and the conserved transcription factor binding sites 
within 1kb. 
 
Table 2  
PANTHER (Protein ANalysis THrough Evolutionary Relationships) analysis of the 
identified genes. Data described as “Molecular functions” and “Biological processes” are 
shown. One relevant reference is shown independently of PANTHER analysis, if any 
available.  
 
Table 3  
Conserved transcription factor binding sites overrepresented in the regions identified by 
chromatin immunoprecipitation. The genomic context of 5 kb of all 26 identified 
immunoprecipitated fragments was analysed. 39 conserved TFBS were found, 12 of them 
beeing present more than one time. Here we present the 6 overrepresented TFBS with 
their corresponding transcription factors, according to the Biobase library and the number 
of their occurencies in the analyzed genomic locations. 
 
GENE NAME CHROMOSOMAL 
LOCATION 
POSITION 
TOWARDS THE 
GENE 
CONSERVED TFBS 
WITHIN 1KB 
AMPH 1 7p14.1 intronic V$ICSBP_Q6 
Cadherin 23 10q22.1 intronic V$S8_01, V$PAX2_01 
Collagen 9 alpha 1 6q13 5‘ V$FOX_Q2, V$MEF2_01 
DCAMKL1 13q13.3 intronic - 
DSU 2q35 intronic V$RORA2_01 
EYA3 1p35.3 intronic - 
IL1A 2q13 5‘ V$FOXP1_01, 
V$BRN2_01 
IL1RAPL2 Xq22.3 intronic - 
KIAA0476 1q21.3 5‘ from predicted 
promoter 
- 
MGC27434 8q24.21 intronic V$OCT1_B 
PAPD1 10p11.23 intronic V$HP1SITEFACTOR_Q6 
ROBO1 3p12.3 intronic V$SOX5_01 
SLC36A1 5q33.1 5‘ - 
SPAG16 2q34 intronic - 
 
Table 1. Balint et al 
Table 2.  Balint et al 
 
GENE NAME PANTHER 
MOLECULAR 
FUNCTION 
PANTHER 
BIOLOGICAL 
PROCESS 
REFERENCE 
AMPH 1 Membrane traffic 
regulatory protein  
Endocytosis  
Transport  
Neurotransmitter 
release  
(Shang, 2004) 
Cadherin 23  Cadherin  Cell adhesion-mediated 
signaling  
Cell adhesion  
Oogenesis  
Embryogenesis  
Anterior/posterior 
patterning  
Heart development  
Cytokinesis  
Cell proliferation and 
differentiation 
(Bolz, 2001) 
Collagen 9 alpha 
1 
Extra cellular matrix 
structural protein  
Cell structure  (Mayne, 1985)  
 
 
DCAMKL1 
 
 
 
 
Non-receptor 
serine/threonine 
protein kinase 
Protein phosphorylation 
Calcium mediated 
signaling  
Neurogenesis  
Cell motility  
(Sossey-Alaoui, 1999) 
 
DSU Unclassified Unclassified (O'Sullivan, 2004) 
 
Table 2.   Continued, Balint et al 
 
GENE NAME PANTHER 
MOLECULAR 
FUNCTION 
PANTHER 
BIOLOGICAL 
PROCESS 
REFERENCE 
EYA3 Other hydrolase  Vision  
Developmental 
processes  
(Li, 2003) 
IL1  Interleukin Cytokine and 
chemokine mediated 
signaling pathway  
Ligand-mediated 
signaling  
Macrophage-mediated 
immunity  
Cytokine/chemokine 
mediated immunity  
Cell cycle control  
Cell proliferation and 
differentiation  
(Lord, 1991) 
IL1RAPL2 Interleukin receptor  Cytokine and 
chemokine mediated 
signaling pathway  
(Khan, 2004) 
KIAA0476 Guanyl-nucleotide 
exchange factor  
Other signal 
transduction  
- 
MGC27434 Unclassified Unclassified (Storlazzi, 2004) 
PAPD1 Unclassified  Unclassified - 
ROBO1 Immunoglobulin 
receptor family 
member  
Defense/immunity 
protein  
Cell adhesion (Rhee, 2002) 
SLC36A1 Other transporter  
Amino acid 
transporter  
Amino acid transport  
Transport  
(Sagne, 2001) 
SPAG16 Microtubule family 
cytoskeletal protein  
Cell motility  - 
 
Table 3.  Balint et al 
 
TF BINDING 
MATRIX 
TRANSCRIPTION 
FACTOR 
NUMBER OF 
OCCURENCES  
V$OCT1_B POU2F1 6 
V$MEF2_Q6_01 MEF-2 5 
V$FREAC7_01 FOXL1 4 
V$PAX4_04 Pax-4a 3 
V$FOXO4_02 FOXO4 3 
V$EVI1_05 Evi-1 3 
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